MTOR and neoplasm: Tumor-derived EVs, containing certain miRNAs, contribute to the enhanced TGF-beta expression in CAFs through the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway [150].